Dinoprostone

carbonyl reductase 1 ; Homo sapiens







65 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35420434 Profiling Glutathionylome in CD38-Mediated Epithelial-Mesenchymal Transition. 2022 May 6 2
2 34522214 Role of prostaglandin E2 in tissue repair and regeneration. 2021 2
3 34655851 Recent advances in studies of 15-PGDH as a key enzyme for the degradation of prostaglandins. 2021 Dec 2
4 32100450 Association between COX-2 and 15-PGDH polymorphisms and SLE susceptibility. 2020 May 2
5 33081378 Prostaglandin E2 Pathway Is Dysregulated in Gastric Adenocarcinoma in a Caucasian Population. 2020 Oct 16 2
6 33210098 Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer. 2020 3
7 30168128 Integrated eicosanoid lipidomics and gene expression reveal decreased prostaglandin catabolism and increased 5-lipoxygenase expression in aggressive subtypes of endometrial cancer. 2019 Jan 2
8 30717608 15-Deoxy-Δ12,14-prostaglandin J2 up-regulates the expression of 15-hydroxyprostaglandin dehydrogenase through DNA methyltransferase 1 inactivation. 2019 Mar 2
9 30931980 miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer. 2019 Apr 1 1
10 31624724 15-Deoxy-Δ12,14-prostaglandin J2 Upregulates the Expression of 15-Hydroxyprostaglandin Dehydrogenase by Inducing AP-1 Activation and Heme Oxygenase-1 Expression in Human Colon Cancer Cells. 2019 Sep 2
11 28239316 15-Hydroxyprostaglandin dehydrogenase as a marker in colon carcinogenesis: analysis of the prostaglandin pathway in human colonic tissue. 2017 Jan 1
12 28402256 A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells. 2017 May 23 2
13 28469926 Primary hypertrophic osteoarthropathy due to a novel SLCO2A1 mutation masquerading as acromegaly. 2017 1
14 28664315 The wound-healing effect of 7,3',4'-trimethoxyflavone through increased levels of prostaglandin E2 by 15-hydroxyprostaglandin dehydrogenase inhibition. 2017 Oct 6
15 28681587 Functional characterization of the promoter of carbonyl reductase 1 gene in porcine endometrial cells. 2017 Jul 2
16 28966256 Anti-cancer Effects of MW-03, a Novel Indole Compound, by Inducing 15-Hydroxyprostaglandin Dehydrogenase and Cellular Growth Inhibition in the LS174T Human Colon Cancer Cell Line. 2017 1
17 29039590 MicroRNA‑218 promotes prostaglandin E2 to inhibit osteogenic differentiation in synovial mesenchymal stem cells by targeting 15‑hydroxyprostaglandin dehydrogenase [NAD(+)]. 2017 Dec 3
18 27010855 GW627368X inhibits proliferation and induces apoptosis in cervical cancer by interfering with EP4/EGFR interactive signaling. 2016 Mar 24 1
19 27075590 HSP90 Inhibition Suppresses PGE2 Production via Modulating COX-2 and 15-PGDH Expression in HT-29 Colorectal Cancer Cells. 2016 Jun 1
20 27561985 MicroRNA-21 regulates prostaglandin E2 signaling pathway by targeting 15-hydroxyprostaglandin dehydrogenase in tongue squamous cell carcinoma. 2016 Aug 25 1
21 25433169 Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer. 2015 Jan-Mar 4
22 25586183 15-Hydroxyprostaglandin dehydrogenase generation of electrophilic lipid signaling mediators from hydroxy ω-3 fatty acids. 2015 Feb 27 1
23 25666316 Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease. 2015 May 5
24 25691459 Omega-3 Polyunsaturated Fatty Acids Upregulate 15-PGDH Expression in Cholangiocarcinoma Cells by Inhibiting miR-26a/b Expression. 2015 Apr 1 3
25 26068950 miR-620 promotes tumor radioresistance by targeting 15-hydroxyprostaglandin dehydrogenase (HPGD). 2015 Sep 8 3
26 26082314 15-hydroxyprostaglandin dehydrogenase is upregulated by hydroxychloroquine in rheumatoid arthritis fibroblast-like synoviocytes. 2015 Sep 4
27 26287481 Expression and Cellular Localization of 15-Hydroxy-Prostaglandin-Dehydrogenase in Abdominal Aortic Aneurysm. 2015 2
28 24471568 Prostaglandin E2 regulates its own inactivating enzyme, 15-PGDH, by EP2 receptor-mediated cervical cell-specific mechanisms. 2014 Mar 10
29 24505358 Decreased PGE₂ content reduces MMP-1 activity and consequently increases collagen density in human varicose vein. 2014 3
30 24654784 Induction of PGF2α synthesis by cortisol through GR dependent induction of CBR1 in human amnion fibroblasts. 2014 Aug 2
31 24699315 miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth. 2014 Jun 2
32 24949321 Relationship between 15-hydroxyprostaglandin dehydrogenase and gastric adenocarcinoma. 2014 Jun 2
33 25458900 Wound healing effects of new 15-hydroxyprostaglandin dehydrogenase inhibitors. 2014 Dec 1
34 25773924 15-Deoxy-Δ12,14-prostaglandin J2 induces expression of 15-hydroxyprostaglandin dehydrogenase through Elk-1 activation in human breast cancer MDA-MB-231 cells. 2014 Oct 2
35 22121107 Combined histone deacetylase and cyclooxygenase inhibition achieves enhanced antiangiogenic effects in lung cancer cells. 2013 Mar 5
36 23442768 Regional differences in prostaglandin E₂ metabolism in human colorectal cancer liver metastases. 2013 Feb 26 2
37 23687300 15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteins. 2013 Jul 5 6
38 23717544 Genetic variation in 15-hydroxyprostaglandin dehydrogenase and colon cancer susceptibility. 2013 4
39 23791868 Control of the intracellular levels of prostaglandin E₂ through inhibition of the 15-hydroxyprostaglandin dehydrogenase for wound healing. 2013 Aug 1 2
40 23954207 Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma. 2013 Nov 2
41 21957267 Hemokinin-1 stimulates prostaglandin E₂ production in human colon through activation of cyclooxygenase-2 and inhibition of 15-hydroxyprostaglandin dehydrogenase. 2012 Jan 2
42 23185705 Prognostic implication of 15-hydroxyprostaglandin dehydrogenase down-regulation in patients with colorectal cancer. 2012 Oct 1
43 21178489 ERG oncogene modulates prostaglandin signaling in prostate cancer cells. 2011 Feb 15 2
44 21426412 Primary hypertrophic osteoarthropathy with digital clubbing and palmoplantar hyperhidrosis caused by 15-PGHD/HPGD loss-of-function mutations. 2011 Jun 2
45 22020925 Prostaglandin catabolic enzymes as tumor suppressors. 2011 Dec 2
46 19820419 Loss of 15-hydroxyprostaglandin dehydrogenase increases prostaglandin E2 in pancreatic tumors. 2010 Apr 3
47 20093479 Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression. 2010 Mar 1
48 19494278 Altered expression of 15-hydroxyprostaglandin dehydrogenase in tumor-infiltrated CD11b myeloid cells: a mechanism for immune evasion in cancer. 2009 Jun 15 1
49 19584167 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer. 2009 Jul 15 1
50 19667157 Prostaglandin metabolizing enzymes in correlation with vitamin D receptor in benign and malignant breast cell lines. 2009 Sep 2